Laser Indirect Ophthalmoscope Market, by Laser Type (Photocoagulating Laser, Photo Disrupting Laser, and Photo Ablating Laser), by Therapeutic Application (Diabetic Retinopathy, Peripheral Neovascularization, Lattice Degeneration, and Others), by End User (Multispecialty Hospitals, Ophthalmic Clinics, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

Published In : Jan 2019

Code : CMI2428

Pages :157

Formats :

Excel and PDF

Industry : Medical Devices

Market Challenges And Opportunities

Increasing prevalence of ophthalmic disorders is expected to support growth of the global laser indirect ophthalmoscope market over the forecast period

Rising prevalence of certain ophthalmic diseases such as peripheral neovascularization, lattice degeneration, and diabetic retinopathy is driving growth of the market. For instance, according to the Royal National Institute of Blind People (RNIB), over 5.7 million people are suffering from sight-threatening eye conditions in the U.K, in 2014. Moreover, 2 million people were suffering from sight loss in 2016, which is expected to increase to over 2.7 million people by 2030. Moreover, according to the Royal National Institute of Blind People (RNIB), in 2014, around 350,000 people were registered as blind or partially sighted. Increasing healthcare expenditures for treatment of sight loss, blindness, and sight-threatening conditions are expected to propel demand for basic eye care and examination, thereby propelling demand for necessary equipment such as laser indirect ophthalmoscopes over the forecast period. According to the RNIB- Eye Health 2016 report, in the U.K., during 2016, sight loss, blindness, and sight-threatening conditions accounted for US$ 2.03 million, US$ 0.27 million, and US$ 5.7 million healthcare expenditures, respectively.

However, product recalls are expected to restrain the global laser indirect ophthalmoscope market growth over the forecast period. For instance, in February 2018, Iridex Corporation voluntarily recalled TruFocus LIO Premiere Laser Indirect Ophthalmoscope, as three adverse events occurred during procedures in which the TruFocus LIO Premiere was used.

Technological advancements in ophthalmoscopes is expected to drive laser indirect ophthalmoscope market growth over the forecast period

Manufacturers such as Welch Allyn, Heine Optotechnik GmbH & Co. KG, Iridex Corporation, Keeler Limited, and others offer technologically advanced laser indirect ophthalmoscopes. Laser indirect ophthalmoscopy offer advantages such as wider field of view, better image resolution, less irritation to the ocular surface, and ease in ophthalmic examination, as the ophthalmoscope is mounted on the forehead of the physician/ophthalmologist. Indirect ophthalmoscopes available today facilitate improvements in eye examination results, and care. For instance, Smart LIO offered by Lumenis is a multiwavelength system in the market, and is compatible with multiple Lumenis photo coagulators. Smart LIO supports three wavelengths such as 532 nm (green), 577 nm (yellow), and 659 nm (red). Other technological advancements include adjustable interpupillary distance, adjustable mirrors, portable power packs, dust sealed optics, and others. These factors are expected to drive the global laser indirect ophthalmoscope market growth over the forecast period.